- call +1-201-465-4211
- email sales@mrinsights.biz
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
Scope of the Report:
North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.
The worldwide market for Pulmonary Drug Delivery Devices/Systems is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Pulmonary Drug Delivery Devices/Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL Group
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Market Segment by Applications, can be divided into
Hospitals and Clinics
Homecare
There are 15 Chapters to deeply display the global Pulmonary Drug Delivery Devices/Systems market.
Chapter 1, to describe Pulmonary Drug Delivery Devices/Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pulmonary Drug Delivery Devices/Systems, with sales, revenue, and price of Pulmonary Drug Delivery Devices/Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pulmonary Drug Delivery Devices/Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pulmonary Drug Delivery Devices/Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pulmonary Drug Delivery Devices/Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Pulmonary Drug Delivery Devices/Systems Introduction
1.2 Market Analysis by Type
1.2.1 Metered Dose Inhalers
1.2.2 Dry Powder Inhalers
1.2.3 Nebulizers
1.2.4 Accessories
1.3 Market Analysis by Applications
1.3.1 Hospitals and Clinics
1.3.2 Homecare
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hovione
2.1.1 Business Overview
2.1.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 3M Health Care
2.2.1 Business Overview
2.2.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bespak
2.3.1 Business Overview
2.3.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BeyonDevices
2.4.1 Business Overview
2.4.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 H&T Presspart
2.6.1 Business Overview
2.6.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PARI Respiratory Equipment
2.7.1 Business Overview
2.7.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Philips Respironics
2.8.1 Business Overview
2.8.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SHL Group
2.9.1 Business Overview
2.9.2 Pulmonary Drug Delivery Devices/Systems Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 SHL Group Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pulmonary Drug Delivery Devices/Systems Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pulmonary Drug Delivery Devices/Systems Manufacturer Market Share in 2017
3.3.2 Top 6 Pulmonary Drug Delivery Devices/Systems Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pulmonary Drug Delivery Devices/Systems Market Analysis by Regions
4.1 Global Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Regions (2013-2018)
4.2 North America Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
4.3 Europe Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
4.5 South America Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
5 North America Pulmonary Drug Delivery Devices/Systems by Countries
5.1 North America Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Countries (2013-2018)
5.2 United States Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
5.3 Canada Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
5.4 Mexico Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
6 Europe Pulmonary Drug Delivery Devices/Systems by Countries
6.1 Europe Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
6.3 UK Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
6.4 France Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
6.5 Russia Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
6.6 Italy Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pulmonary Drug Delivery Devices/Systems by Countries
7.1 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Countries (2013-2018)
7.2 China Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
7.3 Japan Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
7.4 Korea Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
7.5 India Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
8 South America Pulmonary Drug Delivery Devices/Systems by Countries
8.1 South America Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
8.3 Argentina Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
8.4 Colombia Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pulmonary Drug Delivery Devices/Systems by Countries
9.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
9.3 UAE Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
9.4 Egypt Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
9.5 Nigeria Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
9.6 South Africa Pulmonary Drug Delivery Devices/Systems Sales and Growth Rate (2013-2018)
10 Global Pulmonary Drug Delivery Devices/Systems Market Segment by Type
10.1 Global Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pulmonary Drug Delivery Devices/Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Pulmonary Drug Delivery Devices/Systems Revenue and Market Share by Type (2013-2018)
10.2 Metered Dose Inhalers Sales Growth and Price
10.2.1 Global Metered Dose Inhalers Sales Growth (2013-2018)
10.2.2 Global Metered Dose Inhalers Price (2013-2018)
10.3 Dry Powder Inhalers Sales Growth and Price
10.3.1 Global Dry Powder Inhalers Sales Growth (2013-2018)
10.3.2 Global Dry Powder Inhalers Price (2013-2018)
10.4 Nebulizers Sales Growth and Price
10.4.1 Global Nebulizers Sales Growth (2013-2018)
10.4.2 Global Nebulizers Price (2013-2018)
10.5 Accessories Sales Growth and Price
10.5.1 Global Accessories Sales Growth (2013-2018)
10.5.2 Global Accessories Price (2013-2018)
11 Global Pulmonary Drug Delivery Devices/Systems Market Segment by Application
11.1 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2013-2018)
11.2 Hospitals and Clinics Sales Growth (2013-2018)
11.3 Homecare Sales Growth (2013-2018)
12 Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.1 Global Pulmonary Drug Delivery Devices/Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Pulmonary Drug Delivery Devices/Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.2.2 Europe Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.2.4 South America Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Forecast (2018-2023)
12.3 Pulmonary Drug Delivery Devices/Systems Market Forecast by Type (2018-2023)
12.3.1 Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Pulmonary Drug Delivery Devices/Systems Market Share Forecast by Type (2018-2023)
12.4 Pulmonary Drug Delivery Devices/Systems Market Forecast by Application (2018-2023)
12.4.1 Global Pulmonary Drug Delivery Devices/Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Pulmonary Drug Delivery Devices/Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Pulmonary Drug Delivery Devices/Systems Picture
Table Product Specifications of Pulmonary Drug Delivery Devices/Systems
Figure Global Sales Market Share of Pulmonary
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
